|Day Low/High||0.30 / 0.32|
|52 Wk Low/High||0.26 / 0.72|
These under-$10 biotech stocks are within range of triggering breakout trades.
These under-$10 stocks look poised to break out and move higher from current levels.
The Rosen Law Firm, P.A.
Trade-Ideas LLC identified iBio (IBIO) as a "dead cat bounce" (down big yesterday but up big today) candidate
Ebola stocks have soared in recent weeks but a closer look at fundamentals may serve as a reality check for investors playing the story.
Shares of pharmaceutical company iBio (IBIO) plunged in morning trading Monday after some positive announcements about the Ebola outbreak.
Here's how to trade some of the most active stocks on the market today.
Shares of iBio (IBIO) surged again in morning trading Friday as the Ebola outbreak continues.
Trade-Ideas LLC identified iBio (IBIO) as a strong on high relative volume candidate
Shares of iBio (IBIO) soared in morning trading Thursday after the company announced it has offered to aid the U.S. government in fighting Ebola with its proprietary antibody production technology.
Versar (VSR) stock is sharply up today as other Ebola-related stocks tumble following a mixed report by the World Health Organization.
Shares of iBio (IBIO) plunged Tuesday after the World Health Organization said the number of new Ebola cases in the hardest-hit areas is declining.
Trade-Ideas LLC identified iBio (IBIO) as a pre-market mover with heavy volume candidate
Shares of iBio (IBIO) were soaring in morning trading Monday after a nurse in Texas was diagnosed with the Ebola virus, which deepened concerns about an outbreak in the U.S.
Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.
Stocks that are making large moves are favorites among short-term traders because they can try to capture some of that massive volatility.
Traders savvy enough to follow the low-priced names and trade them with discipline and sound risk management are banking ridiculous coin.
iBio, Inc. (NYSE AMEX: IBIO) today announced successful animal testing of a malaria vaccine candidate produced using its proprietary iBioLaunch™ platform and sponsored by the Bill & Melinda Gates Foundation.
TheStreet Ratings released initial ratings on 10 U.S. common stocks in July. Two of these stocks start out at 'sell' and eight earned a recommendation of 'hold' from our stock model.
iBio, Inc. (NYSE AMEX: IBIO) today announced successful production of human plasma proteins using its proprietary iBioLaunch technology.
iBio, Inc. (NYSE AMEX:IBIO), a leader in new transient expression technologies for the development and production of biologics using plants, today announced that it has been added to the Russell Microcap Index,...
iBio, Inc. (NYSE AMEX: IBIO) announced today the appointment of Jules A.
iBio, Inc. (NYSE AMEX: IBIO) announced that an open house for sell-side analysts and institutional fund managers will be held on June 16, 2011, at its Newark, Delaware headquarters, commencing at 10:00 A.
iBio, Inc. (NYSE AMEX: IBIO) today announced positive interim results from a Phase 1 clinical trial of an iBioLaunch™ platform-produced subunit vaccine directed against Influenza A/California/04/09 (H1N1).